Pros | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Lower expense ratio. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | ![]() 3Y returns in the bottom 25% of the category. |
INDMoney rank | 1/8 | 5/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 6 Years | ||
Fund Size | 3671 Cr | 2667 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹99 Lumpsum ₹5000 | ||
Expense Ratio | 0.9% | 0.61% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 32 | 34 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (13.45%) Max Healthcare Institute Ltd Ordinary Shares (6.68%) Divi's Laboratories Ltd (6%) Cipla Ltd (4.79%) Lupin Ltd (4.72%) | Sun Pharmaceuticals Industries Ltd (11.9%) Aurobindo Pharma Ltd (7.12%) Cipla Ltd (6.91%) Divi's Laboratories Ltd (6.6%) Lupin Ltd (6.2%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (93.19%) Basic Materials (6.81%) | Health (98.7%) Basic Materials (1.3%) Industrial (0%) | ||
Equity % | 96.96% | 99.55% | ||
Debt % | - | - | ||
P/E | 44.7 | 34.28 | ||
P/B | 6.41 | 5.04 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 4.87% | 4.48% | ||
3-Month Return | -3% | -4.55% | ||
6-Month Return | -2.68% | -6.58% | ||
1-Year Return | 22.79% | 19.25% | ||
3-Year Return | 27.26% | 21.49% | ||
5-Year Return | 25.72% | 23.62% |
Sharpe | 1.17 | 0.79 | ||
Alpha | 5.32 | -0.29 | ||
Beta | 0.85 | 0.98 | ||
Standard Deviation | 14.89 | 17.07 | ||
Information Ratio | 1.07 | -0.23 |
Description | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Tanmaya Desai | Vrijesh Kasera |